Journal
ENDOCRINE JOURNAL
Volume 59, Issue 11, Pages 955-962Publisher
JAPAN ENDOCRINE SOC
DOI: 10.1507/endocrj.EJ12-0322
Keywords
Growth hormone (GH); Insulin-like growth factor-I (IGF-I); Adult growth hormone deficiency (AGHD); Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH)
Categories
Funding
- Japanese Ministry of Education, Culture, Sports, Science and Technology [19591077, 70301281]
- Ministry of Health, Labor and Welfare, Japan
- Grants-in-Aid for Scientific Research [19591077] Funding Source: KAKEN
Ask authors/readers for more resources
Growth hormone (GH) and insulin-like growth factor-I (IGF-I) play essential roles in growth in childhood, and continue to have important metabolic actions in adults. Adult growth hormone deficiency (AGHD) is characterized by increased visceral adiposity, abnormal lipid profiles, premature atherosclerosis, decreased quality of life, and increased mortality. Recently, case reports and several clinical studies suggest that GHD state in adults is associated with an increased prevalence of nonalcoholic fatty liver disease (NAFLD) and progression to nonalcoholic steatohepatitis (NASH) or liver cirrhosis. As a mechanistic insight, growing evidence has revealed that GH as well as IGF-I play essential roles in the liver. Further investigation is necessary to clarify the precise mechanisms by which GH and IGF-I exert their effects in the liver; however, it should be noted that NAFLD/NASH has emerged as an important comorbidity in AGHD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available